| Dr Leland D Gebhart Iii, MD | |
|
501 Marshall Street, Suite 400, Jackson, MS 39202-1687 | |
| (601) 354-0869 | |
| (601) 352-6521 |
| Full Name | Dr Leland D Gebhart Iii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 501 Marshall Street, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538113899 | NPI | - | NPPES |
| 0120737 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 14966 (Mississippi) | Primary |
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 14966 (Mississippi) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Womans Clinic Of Ms Pllc | 7214003441 | 13 |
News Archive
New research from Wake Forest University has advanced the field of plastic-based flexible electronics by developing, for the first time, an extremely large molecule that is stable, possesses excellent electrical properties, and inexpensive to produce.
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
› Verified 8 days ago
| Entity Name | The Womans Clinic Of Ms Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003843210 PECOS PAC ID: 7214003441 Enrollment ID: O20080911000442 |
News Archive
New research from Wake Forest University has advanced the field of plastic-based flexible electronics by developing, for the first time, an extremely large molecule that is stable, possesses excellent electrical properties, and inexpensive to produce.
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
› Verified 8 days ago
| Entity Name | Obhg Mississippi Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083995674 PECOS PAC ID: 7416120407 Enrollment ID: O20111108000567 |
News Archive
New research from Wake Forest University has advanced the field of plastic-based flexible electronics by developing, for the first time, an extremely large molecule that is stable, possesses excellent electrical properties, and inexpensive to produce.
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
› Verified 8 days ago
| Entity Name | Haven Pregnancy Wellness & Womens Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336824978 PECOS PAC ID: 7315394525 Enrollment ID: O20231109001978 |
News Archive
New research from Wake Forest University has advanced the field of plastic-based flexible electronics by developing, for the first time, an extremely large molecule that is stable, possesses excellent electrical properties, and inexpensive to produce.
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leland D Gebhart Iii, MD 501 Marshall Street, Suite 400, Jackson, MS 39202-1687 Ph: (601) 354-0869 | Dr Leland D Gebhart Iii, MD 501 Marshall Street, Suite 400, Jackson, MS 39202-1687 Ph: (601) 354-0869 |
News Archive
New research from Wake Forest University has advanced the field of plastic-based flexible electronics by developing, for the first time, an extremely large molecule that is stable, possesses excellent electrical properties, and inexpensive to produce.
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
› Verified 8 days ago
Dr. Mary Kinney Lowe Corley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5339 | |
Dr. Sarah Novotny, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Department Of Ob/gyn, Jackson, MS 39216 Phone: 601-984-5358 | |
Dr. Ashley Miller Canizaro, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1020 River Oaks Drive, Suite 310, Jackson, MS 39232 Phone: 601-932-5006 Fax: 601-932-4548 | |
Elizabeth Kaitlyn Mize, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Department Of Obgyn, Jackson, MS 39216 Phone: 601-984-5338 Fax: 601-815-4112 | |
Dr. Virginia A Jones, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 501 Marshall St, Ste 400, Jackson, MS 39202 Phone: 601-354-0869 Fax: 601-352-6521 | |
Dr. William Cleland, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5373 Fax: 601-984-5476 | |
Dr. William Garner Bush, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1020 River Oaks Dr, Suite 410, Jackson, MS 39232 Phone: 601-664-0111 Fax: 601-932-1308 |